The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer's diagnosis in ...

Researchers at the Case Western Reserve School of Medicine have found that when compared to seven other anti-diabetic drugs, ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Prosecutors accused Khazar Momeni of being evasive in her testimony and said her being under the influence of drugs may have ...

The most reliable approach is to use multiple systems in case one fails. If your alarm malfunctions, for example, your mental ...

Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...

Research Ireland Frontiers for the Future projects to make significant impact by boosting our knowledge and delivering innovations in a wide variety of disciplines and settings.

New disease-modifying Alzheimer’s drugs work best when they are given to patients in the early stages of disease. The drug has been licensed for use in the UK but rejected by th ...

NHS spending watchdog says donanemab - available to 70,000 people in England and Wales - 'does not currently demonstrate ...

A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...

Donanemab, manufactured by pharmaceutical giant Eli Lilly, is a targeted antibody drug which slows down the early stages of Alzheimer's. It was approved by the medicines regulator on Wednesday, but ...

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending ...